Menu
Intsel Chimos is your future a partner, dedicated to ensuring early access to innovative therapies and to supporting patients with rare disease.
As a distinguished distributor and operator of compassionate and/or early access medicines (AAC/AAP), we provide solutions to patients whose needs are unmet by currently available French treatments.
Intsel Chimos has acquired in-depth knowledge of and familiarity with the French and European healthcare systems. We are fully dedicated to supporting our partners in navigating these systems successfully across all therapeutic areas.
Intsel Chimos has developed expertise that allows it to be reactive and flexible in the acquisition and distribution of various pharmaceutical specialties to hospitals and retail pharmacies.
As a pharmaceutical company, Intsel Chimos is committed to supporting our partners’ success at all stages : registration, marketing, and commercialization of drugs. We aim to accomplish this in the simplest and most efficient way possible, while maintaining strict compliance with the French and European regulations.